SAMIRA QUEEN: Open Payments
NPI 1871081703 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 25 payments from 14 companies in 2025. Trend: 2023 $679 · 2024 $590 · 2025 $634
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $95 |
| Medtronic, Inc. | 3 | $79 |
| Bolton Medical Inc | 3 | $73 |
| ABIOMED | 3 | $65 |
| AtriCure, Inc. | 2 | $63 |
| Becton, Dickinson and Company | 1 | $60 |
| Ethicon US, LLC | 1 | $40 |
| Solventum Corporation | 2 | $32 |
| Endologix LLC | 1 | $31 |
| Acera Surgical, Inc. | 1 | $29 |
Products named: Wegovy, ENDURANT IIS, TREO ABDOMINAL STENT-GRAFT SYSTEM, PROLENE, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Torus Stent Graft System, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, Restrata Wound Matrix.
Industry payments across OK — which companies pay providers there.
